Featured Research

from universities, journals, and other organizations

Genetic Mutations Linked To Rare Metabolic Disease

Date:
March 8, 1999
Source:
Ohio State University
Summary:
Researchers have identified two mutations in a single gene as the cause of a very rare metabolic disease that affects people in Finland, Norway and Saudi Arabia. It has taken nearly 40 years since the identification of the disease for researchers to trace its cause back to a faulty gene.

COLUMBUS, Ohio -- Researchers have identified two mutations in a single gene as the cause of a very rare metabolic disease that affects people in Finland, Norway and Saudi Arabia. It has taken nearly 40 years since the identification of the disease for researchers to trace its cause back to a faulty gene.

Related Articles


An international team of a dozen scientists, including those from Ohio State University, reported their discovery in the latest issue of the journal Nature Genetics.

Called megaloblastic anemia 1, or Imerslund-Grasbeck syndrome after the two researchers who first described it, the defects prevent the normal absorption of vitamin B-12. If left untreated, the disease can be fatal. While serious, the syndrome is exceedingly rare -- only one person in a million may develop this disease. The disease has also been identified in patients from Israel, Turkey, Kuwait and the United States as well.

For this study, scientists mapped the DNA of 17 Finnish patients who had the disease, comparing it to disease-free control subjects. They also looked at DNA samples from patients in Norway, as well as members of a Bedouin family in Saudi Arabia, all of whom had the disease.

Researchers have known that the disorder was autosomally recessive, that is, it occurs only when a child inherits a bad copy of the gene from each parent. People who inherit a single bad gene are still able to metabolize vitamin B-12. Normally, vitamin B-12 binds to another compound in the body called intrinsic factor to form a chemical complex the body can use.

“But the gene mutation alters the three-dimensional structure of the protein cubilin that’s required to make that complex,” explains Ralf Krahe, an assistant professor of microbiology and immunology and a researcher with Ohio State’s Comprehensive Cancer Center.

“This is a very subtle change. It doesn’t completely destroy the protein -- it just changes a particular amino acid, proline, to leucine.”

The actual shape of protein molecules plays a major role in how they function. Proline normally causes a bend in the protein molecule at a specific place and in a specific direction. When the leucine was substituted for the proline, no bend was produced and the molecule malfunctioned.

This major Finnish mutation, called FM1, is responsible for 91 percent of the disease chromosomes studied during the project. The researchers also discovered a minor Finnish mutation, dubbed FM2, which, when the two are considered together, accounts for 97 percent of the mutant Finnish chromosomes. Both mutations are in the Cubilin (CUBN) gene.

Krahe, along with Maria Aminoff, a doctoral student from the University of Helsinki and visiting scientist at Ohio State, and Albert de la Chapelle, director of the Human Cancer Genetics Program at Ohio State, all believe that there is a third Finnish mutation -- FM3 -- waiting to be discovered.

This work on the genetic cause of megaloblastic anemia 1 was helped by the fact that it is more prevalent in Finland. Historically, the Finnish population has been isolated by geographic borders, Aminoff said. This confined these genetic mutations within a tight group of people.

At the same time, extensive medical and genealogical records are maintained by the Finnish government, and detailed marriage records are maintained by the church in that country. Together, these provide excellent tools for tracing the origin and spread of the gene mutations through the populations, she said. Krahe and his colleagues estimate the gene mutations began to spread as early as 1,000 to 1,300 years ago.

Along with the two identified Finnish mutations and the one that’s as yet undiscovered, the researchers believe that two other mutations in Norwegian patients may be linked to the disease and at least one mutation from the Bedouin family.

“That’s a total of six mutations in three distinct populations,” Krahe said.

Researchers from the University of Helsinki, the Minerva Foundation Institute for Medical Research in Helsinki, the National Guard King Khalid Hospital in Saudi Arabia, Vestfold Central Hospital in Norway, University of Aarhus in Denmark, and the Hospital Tenon in Paris participated in the study. Funding was provided by the Ulla Hjelt Fund, Liv och Halsa, the Academy of Finland and the National Cancer Institute.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Genetic Mutations Linked To Rare Metabolic Disease." ScienceDaily. ScienceDaily, 8 March 1999. <www.sciencedaily.com/releases/1999/03/990308054959.htm>.
Ohio State University. (1999, March 8). Genetic Mutations Linked To Rare Metabolic Disease. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/1999/03/990308054959.htm
Ohio State University. "Genetic Mutations Linked To Rare Metabolic Disease." ScienceDaily. www.sciencedaily.com/releases/1999/03/990308054959.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins